Draeger Medical, Inc. Shareholders Elect a New Supervisory Board

LUEBECK, Germany, May 9 /PRNewswire/ -- As expected, the candidates proposed by the Supervisory Board’s Nomination Committee were today elected by the annual general meeting of Draegerwerk AG & Co. KGaA to the Supervisory Board:

At its constituent meeting following the annual general meeting, the Supervisory Board unanimously elected Dr. Nikolaus Schweickart as its Chairman.

Siegfrid Kasang, Daniel Friedrich, Bernd Mussmann, Walter Neundorf, Thomas Rickers and Ulrike Tinnefeld were elected as employee representatives to the Supervisory Board on April 8, 2008.

Furthermore, the annual general meeting approved the proposed dividend.

The dividend for fiscal year 2007 is EUR 0.55 per preferred share and EUR 0.49 per common share. Moreover, the annual general meeting authorized the management to buy back up to 10 percent of the preferred treasury shares until 8 November 2009.

Around 1,300 shareholders bid farewell to the retiring Supervisory Board at the Lubeck Music and Congress Center. They thanked the Supervisory Board members for their hard work throughout their five-year term in office.

Prof. Dr. Dieter Feddersen, the outgoing Chairman of the Supervisory Board, wished the elected successors every success in taking over the reins and endorsed the Chairman of the Executive Board’s strategy in applying the principle of “Draeger. Technology for Life”.

In his capacity as shareholder, Stefan Draeger paid tribute to Prof. Dr. Dieter Feddersen’s achievements over the many years. He became a member of the Supervisory Board in 1973 and had been its Chairman since 1979. Prof. Feddersen will continue to support Draeger in the future, for example on the Executive Board of the Foundation.

Those who have left the Supervisory Board are:

Professor Dr. Dieter Feddersen, Theo Draeger, Dr. Thomas Lindner, Dr. Martin Posth, Gordon Riske and Dr. Dietrich Schulz. Theo Draeger had become a member of the Supervisory Board in 2005, after 35 years of service, many of which as the CFO and as Chairman of the Executive Board.

Draeger. Technology for Life(R)

Draegerwerk AG & Co. KGaA is an internationally leading medical and safety technology group. Draeger products protect, support and save lives. Established in 1889, in 2007 Draeger generated net sales of around EUR 1.8 billion. The Luebeck-based technology corporation is represented in 190 countries and has around 10,000 employees worldwide. Please visit www.draeger.com for more information.

CONTACT: Corporate Communications, Burkard Dillig, +49-451-882-2185,
burkard.dillig@draeger.com, or Investor Relations, Vanina Herbst,
+49-451-882-2685, vanina.herbst@draeger.com

Web site: http://www.draeger.com/

MORE ON THIS TOPIC